Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the ...

Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

Following the Swiss authorization, eight African nations that participated in a joint regulatory review process are now ...

Swiss medicines regulator Swissmedic has approved Coartem Baby, a Novartis anti-malaria drug developed for infants weighing between two and five kilos.

The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight ...

For the first time ever, a malaria treatment has been approved for infants, according to a press release by pharmaceutical ...